Earnings History for Anacor Pharmaceuticals (ANAC)
|
Expand Research on ANAC
| Next EPS Date | 8/8/13 *Est. | EPS Growth Rate | +12.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.0% | Revenue Growth Rate | -29.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.9% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/11  |
 |
Q311 | -$0.16 | -$0.41 | +$0.25 | $12.6M | $16.9M | N/A / N/A | N/A | -6.2% | Details |
| 3/13/12 |
Q411 | -$0.52 | -$0.35 | -$0.17 | $2.6M | $6.64M | N/A / N/A | N/A | -1.8% | Details | |
| 5/5/11 |
|
Q111 | -$0.49 | -$0.31 | -$0.18 | $2.2M | $4.38M | N/A / N/A | N/A | -8.1% | Details |
| 8/11/11 |
|
Q211 | -$0.54 | -$0.45 | -$0.09 | $2.86M | $4M | N/A / N/A | N/A | +4.8% | Details |
| 5/10/12 |
|
Q112 | -$0.48 | -$0.43 | -$0.05 | $2.42M | $3.65M | N/A / N/A | N/A | -1.8% | Details |
| 3/14/13 |
|
Q412 | -$0.36 | -$0.44 | +$0.08 | $3.29M | $3.25M | N/A / N/A | N/A | +47.8% | Details |
| 11/7/12 |
|
Q312 | -$0.46 | -$0.45 | -$0.01 | $2.5M | $3.18M | N/A / N/A | N/A | +3.2% | Details |
| 8/9/12 |
|
Q212 | -$0.47 | -$0.45 | -$0.02 | $2.6M | $3.11M | N/A / N/A | N/A | -10.6% | Details |
